JP2000310633A - 健康管理装置 - Google Patents
健康管理装置Info
- Publication number
- JP2000310633A JP2000310633A JP2000043838A JP2000043838A JP2000310633A JP 2000310633 A JP2000310633 A JP 2000310633A JP 2000043838 A JP2000043838 A JP 2000043838A JP 2000043838 A JP2000043838 A JP 2000043838A JP 2000310633 A JP2000310633 A JP 2000310633A
- Authority
- JP
- Japan
- Prior art keywords
- measurement
- urine
- sensor
- liquid
- excrement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims description 54
- 238000005259 measurement Methods 0.000 claims abstract description 230
- 239000007788 liquid Substances 0.000 claims abstract description 162
- 210000003608 fece Anatomy 0.000 claims abstract 4
- 210000002700 urine Anatomy 0.000 claims description 265
- 238000003860 storage Methods 0.000 claims description 45
- 238000001514 detection method Methods 0.000 claims description 30
- 238000012546 transfer Methods 0.000 claims description 26
- 238000012545 processing Methods 0.000 claims description 22
- 238000007599 discharging Methods 0.000 claims description 11
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 9
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 9
- 229940116269 uric acid Drugs 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 230000009471 action Effects 0.000 claims description 5
- 229910001415 sodium ion Inorganic materials 0.000 claims description 4
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 98
- 239000000872 buffer Substances 0.000 abstract description 55
- 238000005406 washing Methods 0.000 abstract description 21
- 238000005070 sampling Methods 0.000 abstract 4
- 206010018473 Glycosuria Diseases 0.000 abstract 2
- 239000007853 buffer solution Substances 0.000 description 72
- 239000012482 calibration solution Substances 0.000 description 70
- 238000000034 method Methods 0.000 description 39
- 238000010438 heat treatment Methods 0.000 description 34
- 238000007726 management method Methods 0.000 description 31
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 28
- 239000000523 sample Substances 0.000 description 28
- 238000009535 clinical urine test Methods 0.000 description 23
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 21
- 239000008103 glucose Substances 0.000 description 21
- 230000008859 change Effects 0.000 description 20
- 238000004140 cleaning Methods 0.000 description 18
- 238000010586 diagram Methods 0.000 description 18
- 230000008569 process Effects 0.000 description 16
- 238000007710 freezing Methods 0.000 description 14
- 230000008014 freezing Effects 0.000 description 14
- 238000004891 communication Methods 0.000 description 13
- 239000000460 chlorine Substances 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000004364 calculation method Methods 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 238000003825 pressing Methods 0.000 description 6
- 230000002485 urinary effect Effects 0.000 description 6
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 5
- 230000005856 abnormality Effects 0.000 description 5
- 244000052616 bacterial pathogen Species 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 208000033679 diabetic kidney disease Diseases 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- 238000009434 installation Methods 0.000 description 4
- 239000004973 liquid crystal related substance Substances 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 108010015776 Glucose oxidase Proteins 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 238000005429 filling process Methods 0.000 description 3
- 229940116332 glucose oxidase Drugs 0.000 description 3
- 235000019420 glucose oxidase Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 235000015598 salt intake Nutrition 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- -1 KCl ion Chemical class 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000007257 malfunction Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000010006 flight Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000008400 supply water Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 238000005353 urine analysis Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000043838A JP2000310633A (ja) | 1999-02-23 | 2000-02-22 | 健康管理装置 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4560999 | 1999-02-23 | ||
| JP11-45609 | 1999-02-23 | ||
| JP2000043838A JP2000310633A (ja) | 1999-02-23 | 2000-02-22 | 健康管理装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000310633A true JP2000310633A (ja) | 2000-11-07 |
| JP2000310633A5 JP2000310633A5 (enExample) | 2007-04-05 |
Family
ID=26385630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000043838A Pending JP2000310633A (ja) | 1999-02-23 | 2000-02-22 | 健康管理装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000310633A (enExample) |
-
2000
- 2000-02-22 JP JP2000043838A patent/JP2000310633A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5514442B2 (ja) | 人体体液の定量及び定性分析装置 | |
| JP4329123B2 (ja) | 尿分析方法 | |
| JP2001066277A (ja) | 検出装置および尿分析装置 | |
| JP2001066299A (ja) | 検出装置および尿分析装置 | |
| JP2002071637A (ja) | 電気化学センサーの出力分析方法及び尿検査装置 | |
| JP2000241423A (ja) | 健康管理装置 | |
| JP2000241415A (ja) | 健康管理装置 | |
| JP2002071635A (ja) | 物質濃度定量方法及び装置 | |
| JP3598864B2 (ja) | 健康管理装置 | |
| JP2000310636A (ja) | 健康管理装置 | |
| JP2000241411A (ja) | 健康管理装置 | |
| JP3649020B2 (ja) | 健康管理装置 | |
| JP2000310635A (ja) | 健康管理装置 | |
| JP2000310632A (ja) | 健康管理装置 | |
| JP3598866B2 (ja) | 健康管理装置 | |
| JP3598865B2 (ja) | 健康管理装置 | |
| JP3624756B2 (ja) | 分析装置 | |
| JP2000310634A (ja) | 健康管理装置 | |
| JP3624735B2 (ja) | 健康管理装置 | |
| JP2001066285A (ja) | 検出装置および尿分析装置 | |
| JP2000310633A (ja) | 健康管理装置 | |
| JP3620328B2 (ja) | 健康管理装置 | |
| JP2000241412A (ja) | 健康管理装置 | |
| JP2001066286A (ja) | 検出装置および尿分析装置 | |
| JP3649021B2 (ja) | 健康管理装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070219 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070219 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090401 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090907 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100106 |